Isoniazid
- Product NDC
- 61748-013
- 11-digit product format
- 617480013
- Labeler code
- 61748
- Product ID
- 61748-013_1247f0c8-25be-49b0-96e1-22b1cf50dc00
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Isoniazid
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- VersaPharm Incorporated
- Application
- ANDA087425
- Marketing category
- ANDA
- Marketing start
- 1997-09-01
- Marketing end
- 0000-00-00
- Substance
- ISONIAZID
- Active strength
- 300 mg/1
- Pharmacologic classes
- Antimycobacterial [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 61748-013-01 | Isoniazid | 100 in 1 BOTTLE | TABLET | 100 | | 1 |
| 61748-013-10 | Isoniazid | 1000 in 1 BOTTLE | TABLET | 1000 | | 1 |
| 61748-013-30 | Isoniazid | 30 in 1 BOTTLE | TABLET | 30 | | 1 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| ISONIAZID | ACTIVE INGREDIENT | V83O1VOZ8L | ISONIAZID TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| ISONIAZID | ACTIVE INGREDIENT | V83O1VOZ8L | ISONIAZID TABLET [VERSAPHARM INCORPORATED] | 1 | |
| ISONIAZID | ACTIVE INGREDIENT | V83O1VOZ8L | ISONIAZID TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| ISONIAZID | ACTIVE MOIETY | V83O1VOZ8L | ISONIAZID TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| ISONIAZID | ACTIVE MOIETY | V83O1VOZ8L | ISONIAZID TABLET [VERSAPHARM INCORPORATED] | 1 | |
| ISONIAZID | ACTIVE MOIETY | V83O1VOZ8L | ISONIAZID TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | ISONIAZID TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | ISONIAZID TABLET [VERSAPHARM INCORPORATED] | 1 | |
| ANHYDROUS LACTOSE | INACTIVE INGREDIENT | 3SY5LH9PMK | ISONIAZID TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| CALCIUM STEARATE | INACTIVE INGREDIENT | 776XM7047L | ISONIAZID TABLET [VERSAPHARM INCORPORATED] | 1 | |
| CALCIUM STEARATE | INACTIVE INGREDIENT | 776XM7047L | ISONIAZID TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| CALCIUM STEARATE | INACTIVE INGREDIENT | 776XM7047L | ISONIAZID TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ISONIAZID TABLET [VERSAPHARM INCORPORATED] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ISONIAZID TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | ISONIAZID TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ISONIAZID TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ISONIAZID TABLET [VERSAPHARM INCORPORATED] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | ISONIAZID TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | ISONIAZID TABLET [VERSAPHARM INCORPORATED] | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | ISONIAZID TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | ISONIAZID TABLET [BLENHEIM PHARMACAL, INC.] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 61748-013 | ISONIAZID TABLET [VERSAPHARM INCORPORATED] | 1 | Legacy NDC, 3 package rows | 20120803_1247f0c8-25be-49b0-96e1-22b1cf50dc00.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 61748-013-01 | 61748001301 | 100 in 1 BOTTLE | Historical |
| 61748-013-10 | 61748001310 | 1000 in 1 BOTTLE | Historical |
| 61748-013-30 | 61748001330 | 30 in 1 BOTTLE | Historical |